Schonfeld Strategic Advisors LLC Solid Biosciences Inc. Transaction History

Schonfeld Strategic Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$3.49 - $5.51 $456,544 - $720,790	-130,815 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$5.37 - $10.72 $702,476 - $1.4 Million	130,815 New	130,815 $723,000
Q3 2019 Nov 14, 2019	SELL	$4.33 - $11.64 $204,376 - $549,408	-47,200 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$4.6 - $10.13 $217,119 - $478,136	47,200 New	47,200 $271,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $35.2M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.